Advertisement
Handelsregister und Firmendaten zu Bonität und Betreibungen von Monetas

GENE PREDICTIS SA

GENE PREDICTIS SA

Bâtiment B

EPFL Innovation Park

1015Lausanne

    • Legal form:

    • Joint Stock Company (CH)

    • Status:

    • Active

    • Capitalisation:

    • CHF 142'320.00

    • Year of foundation:

    • 2004

    • D-U-N-S® Nbr.:

    • 48-271-1202

Below and under the following menu items you can find all important information on GENE PREDICTIS SA. In addition to public data, you can find information on payment histories, history, company structure and finances, along with how the responsible persons are interlinked.

Take a closer look!

screen_bonitaetsauskunft

Credit check

Find out more about payment capacity and avoid surprises.

Debt collection extractCredit check

Free company monitoring

We will notify you of any important changes.

Commercial register

    • Trade registry entry:

    • 19.07.2004

    • Registered office:

    • 1024 Ecublens VD

    • HR number:

    • CH-217.3.531.460-1

    • UID:

    • CHE-111.777.642

    • CR office:

    • Canton Vaud

    • Statutory auditor:

    • Baker & Norton Fiduciaire SA

Management & staff

Financial matters

    • Credit check:

    • Find out about the credit standing, creditworthiness and payment capacity of GENE PREDICTIS SA here.

      We have been able to analyse the payment behaviour of GENE PREDICTIS SA with respect to a total of 9 invoices.

      Check creditworthiness

    • Debt-collection report:

    • We do not yet have a debt enforcement report.

      Would you like to know whether any debt enforcements have been recorded for the company GENE PREDICTIS SA? We will gladly obtain an up-to-date report from the responsible debt enforcement office – you can order the report here.

      Order a debt enforcement report

    • Risk report:

    • Would you like all info at a glance? The risk report for GENE PREDICTIS SA combines the creditworthiness, score, real payment histories and a debt enforcement excerpt in one report.

      Risk report

    • Creditworthiness certificate:

    • Companies that have had high creditworthiness for several years can have this confirmed with a document.

      Creditworthiness certificate

Company names & contact

Activity

    • Purpose of company:

    • Cette société a pour but principal la promotion du diagnostic prédictif dans le domaine de la génétique, l'exploitation des analyses médicales, la formation et la recherche en génétique, ainsi que le développement de nouveaux produits dans le domaine de la biologie moléculaire (pour but complet cf. statuts).

    • Branch office(s):

    • Medical laboratories

    • NOGA 2008:

    • 869006

News

NIMGenetics expands in Europe with the acquisition of Gene Predictis

13.02.2023

NIMGenetics, a leading Spanish biotech company in the field of human genetic diagnostics, continues its expansion in Europe with the acquisition of the Swiss
diagnostic company Gene Predictis, a leader in the field of preventive health and precision
medicine.
This acquisition reinforces NIMGenetics' firm intent to its international expansion, with a focus on Central European markets. The synergies of both portfolios, as well as customer growth for both companies, will place NIMGenetics at the forefront of the genetic diagnostics market in Europe.
Gene Predictis' location in the EPFL Innovation Park in Lausanne (Ecole Polytechnique Fédérale de Lausanne) positions the Spanish biotech in a context with a strong innovative component, within an environment focused on the biotech, pharmaceutical and food tech industries.
Enrique Samper, co-founder and CEO of NIMGenetics, believes that "this acquisition will boost our expansion in Europe and usher in a new phase of development marked by future strategic alliances".
Gene Predictis CEO, Goranka Tanackovic, describes the integration into the group as "a great opportunity to expand our activity internationally, and to focus on our main areas of expertise".
Apposite Capital, majority investor in NIMGenetics, says the deal demonstrates the company's ability to lead the market by adding partner firms such as Gene Predictis, aligned with its existing offering of high-quality genomic products and services.
BDO, Pinsent, Avest, BAT Law and Kellerhals-Carrard advised on the transaction.

Show additional news

Vicinity

Company verification badge

Show your website visitors that GENE PREDICTIS SA is registered in the trade register by embedding this badge on your website.

Edit entry

  • Edit entry

  • Do you have any additions or corrections for our data?

    Edit entry
Advertisement
Advertisement